Jia Zhong

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Radiation Induced

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Thoracic cancer

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Zhao, Wei Zhuang, Boyang Sun, Hua Bai, Zhijie Wang, Jia Zhong, Rui Wan, Lihui Liu, Jianchun Daun, Jie Wang
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer (2024)
Jie Zhao, Wei Zhuang, Boyang Sun, Hua Bai, Zhijie Wang, Jia Zhong, Rui Wan, Lihui Liu, Jianchun Daun, Jie Wang
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (13) (2024)
Jie Zhao, Wei Zhuang, Boyang Sun, Hua Bai, Zhijie Wang, Jia Zhong, Rui Wan, Lihui Liu, Jianchun Daun, Jie Wang
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (13) (2024)
Jie Zhao, Wei Zhuang, Boyang Sun, Hua Bai, Zhijie Wang, Jia Zhong, Rui Wan, Lihui Liu, Jianchun Daun, Jie Wang
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (13) (2024)
Boyang Sun, Tian Qiu, Xiaoling Zeng, Jianchun Duan, Hua Bai, Jiachen Xu, Jin Li, Jun-Ling Li, Xuezhi Hao, Yutao Liu, Lin Lin, Hongyu Wang, Xin Zhang, Jia Zhong, Jie Wang, Jianming Ying, Zhijie Wang
Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors. Cancer research communications 3 (4) (2023)
Kai Chen, Wen Li, Xiaoming Xi, Jia Zhong
A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy. Thoracic cancer 13 (21) (2022)
Shuhang Wang, Qiuping Liang, Yujia Chi, Minglei Zhuo, Tongtong An, Jianchun Duan, Zhijie Wang, Yuyan Wang, Jia Zhong, Xue Yang, Hanxiao Chen, Jie Wang, Jun Zhao
Retrospective analysis of the effectiveness and tolerability of nab-paclitaxel in Chinese elderly patients with advanced non-small-cell lung carcinoma. Thoracic cancer 11 (5) (2020)
Jia Zhong, Qiwen Zheng, Tongtong An, Jun Zhao, Meina Wu, Yuyan Wang, Minglei Zhuo, Jianjie Li, Xinghui Zhao, Xue Yang, Bo Jia, Hanxiao Chen, Zhi Dong, Jingjing Wang, Yujia Chi, Xiaoyu Zhai, Ziping Wang
Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis. Thoracic cancer 10 (9) (2019)
Xue Yang, Minglei Zhuo, Anhui Shi, Shengnan Yang, Ziping Wang, Meina Wu, Tongtong An, Yuyan Wang, Jianjie Li, Jia Zhong, Hanxiao Chen, Bo Jia, Zhi Dong, Jun Zhao
Optimal first-line treatment for advanced thymic carcinoma. Thoracic cancer 10 (11) (2019)
Jia Zhong, Zihan Guo, Liping Fan, Xinghui Zhao, Bingqing Zhao, Zhigang Cao, Linlin Cheng, Yuanyuan Shi, Xiaoting Li, Yanhua Zhang, Tongtong An, Meina Wu, Yuyan Wang, Minglei Zhuo, Jianjie Li, Xue Yang, Hanxiao Chen, Bo Jia, Jun Zhao
ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. Thoracic cancer 10 (11) (2019)